NCT00197171View on ClinicalTrials.gov

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

PHASE3CompletedINTERVENTIONAL

Enrollment

143

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Hepatitis BHepatitis A

Interventions

BIOLOGICAL

Combined Hepatitis A and B vaccine

Trial Locations (2)

2124

GSK Investigational Site, Paramatta

3001

GSK Investigational Site, Melbourne

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY